Hyaluronic Acid Products Market

Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL2033
  • Published On : Apr 2014
  • No. of Pages : 106
  • Category : Healthcare

Table of Content
 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
      1.3.2 Assumptions and Stipulations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
      2.1.1 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
2.2 Comparative Analysis: Global Hyaluronic Acid Products Market, By Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
      3.2.1 Drivers
      3.2.2 Restraints
      3.2.3 Market Opportunities
3.3 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of Substitutes
      3.3.4 Threat of New Entrants
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis
      3.4.1 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
3.5 Global Market Share Analysis for the Hyaluronic Acid Products, by Key Players, 2012 (Value %)
      3.5.1 Global Market Share by Key Players, 2012 (Value %)
 
Chapter 4 Global Hyaluronic Acid Products Market, by Products
4.1 Overview
      4.1.1 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Single-Injection Cycle Products
      4.2.1 Global Single-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.3 Three-Injection Cycle Products
      4.3.1 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.4 Five-Injection Cycle Products
      4.4.1 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 5 Global Hyaluronic Acid Products Market, by Applications
5.1 Overview
      5.1.1 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Osteoarthritis
      5.2.1 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
5.3 Ophthalmic
      5.3.1 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
5.4 Dermal Fillers
      5.4.1 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
5.5 Vesicoureteral Reflux (VUR)
      5.5.1 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)
 
Chapter 6 Global Hyaluronic Acid Products Market, by Geography
6.1 Overview
      6.1.1 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Focus on improving technology in order to increase the accuracy and reduce side-effects
      7.1.2 Multinational companies established partnership with the local professional/organization to expand their business
7.2 Barriers to be considered
      7.2.1 High cost is a barrier for sufficient market expansion
 
Chapter 8 Company Profiles
8.1 Alcon, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Allergan, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Anika Therapeutics, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 F. Hoffmann-La Roche Ltd.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Ferring Pharmaceuticals, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Fidia Farmaceutici SpA
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product portfolio
      8.6.4 Business Strategies
      8.6.5 Recent developments
8.7 GALDERMA S.A.
      8.7.1 Company Profile
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Hyaltech Ltd.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 LifeCore Biomedical LLC,
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Meiji Seika Pharma Co., Ltd.
      8.10.1 Company Profile
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Merz Aesthetics, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Sanofi
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Salix Pharmaceuticals, Inc.
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments
8.14 Seikagaku Corporation
      8.14.1 Company Overview
      8.14.2 Financial Overview
      8.14.3 Product Portfolio
      8.14.4 Business Strategies
      8.14.5 Recent Developments
8.15 Shanghai Jingfeng Pharmaceutical Co., Ltd.
      8.15.1 Company Overview
      8.15.2 Financial Overview
      8.15.3 Product Portfolio
      8.15.4 Business Strategies
      8.15.5 Recent Developments
8.16 Smith & Nephew plc
      8.16.1 Company Overview
      8.16.2 Financial Overview
      8.16.3 Product Portfolio
      8.16.4 Business Strategies
      8.16.5 Recent Development
8.17 TRB CHEMEDICA INTERNATIONAL SA
      8.17.1 Company Overview
      8.17.2 Financial Overview
      8.17.3 Product Portfolio
      8.17.4 Business Strategies
      8.17.5 Recent Developments
8.18 Zimmer Holdings, Inc.
      8.18.1 Business Overview
      8.18.2 Financial Overview
      8.18.3 Product Portfolio
      8.18.4 Business Strategies
      8.18.5 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
TABLE 2 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 –2019 (USD Million)
TABLE 3 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 –2019 (USD Million)
TABLE 4 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 –2019 (USD Million)

List of Figures
 
FIG. 1 Hyaluronic Acid Products: Market Segmentation
FIG. 2 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
FIG. 5 Production Methods of Hyaluronic acid
FIG. 6 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
FIG. 7 Market Share Analysis: Hyaluronic Acid Products Market, 2012 (Value %)
FIG. 8 Comparative Analysis: Types of Hyaluronic Acid Products
FIG. 9 Global Single-Injection Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
FIG. 13 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
FIG. 14 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
FIG. 15 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)
FIG. 16 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Alcon, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Allergan, Inc., Annual Sales Revenue: 2010 – 2012 (USD Million)
FIG. 22 Anika Therapeutics, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 23 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Galderma S.A., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Lifecore Biomedical LLC., Annual Revenue: 2010– 2012 (USD Million)
FIG. 26 Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Merz Aesthetics Inc., Annual revenue: 2010 – 2012 (USD Million)
FIG. 28 Sanofi, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2012 (USD Million)
FIG. 30 Seikagaku Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Smith & Nephew PLC, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc., Annual Revenue: 2010 – 2012 (USD Million)